Kuwait has approved the COVID-19 vaccine developed by Johnson & Johnson, the state-news agency KUNA reported on Tuesday.
It is the fourth vaccine approved by Kuwait after those of Pfizer BioNTech, AstraZeneca and Moderna.
The Gulf state has reported around 319,000 infections, 302,000 recoveries and 1,798 fatalities from the virus.